Caveolin-1-Mediated Cholesterol Accumulation Contributes to Exaggerated mGluR-Dependent Long-Term Depression and Impaired Cognition in Fmr1 Knockout Mice

[1]  F. Corbin,et al.  Association of lipid rafts cholesterol with clinical profile in fragile X syndrome , 2022, Scientific Reports.

[2]  R. Hagerman,et al.  Fragile X Syndrome: From Molecular Aspect to Clinical Treatment , 2022, International journal of molecular sciences.

[3]  J. Trojanowski,et al.  Synapsin-caveolin-1 gene therapy preserves neuronal and synaptic morphology and prevents neurodegeneration in a mouse model of AD , 2021, Molecular therapy. Methods & clinical development.

[4]  D. Buonomano,et al.  Decreased reproducibility and abnormal experience-dependent plasticity of network dynamics in Fragile X circuits , 2020, Scientific Reports.

[5]  C. B. Smith,et al.  Effects of the presence and absence of amino acids on translation, signaling, and long‐term depression in hippocampal slices from Fmr1 knockout mice , 2019, Journal of neurochemistry.

[6]  W. Ho,et al.  Association of mGluR-Dependent LTD of Excitatory Synapses with Endocannabinoid-Dependent LTD of Inhibitory Synapses Leads to EPSP to Spike Potentiation in CA1 Pyramidal Neurons , 2018, The Journal of Neuroscience.

[7]  E. Klann,et al.  Turning up translation in fragile X syndrome , 2018, Science.

[8]  Regina Dahlhaus.  Of Men and Mice: Modeling the Fragile X Syndrome , 2018, Front. Mol. Neurosci..

[9]  T. C. Dockendorff,et al.  The Fragile X Protein and Genome Function , 2018, Molecular Neurobiology.

[10]  G. Hotamisligil,et al.  NRF1 Is an ER Membrane Sensor that Is Central to Cholesterol Homeostasis , 2017, Cell.

[11]  T. Kuner,et al.  Selective Phosphorylation of AMPA Receptor Contributes to the Network of Long-Term Potentiation in the Anterior Cingulate Cortex , 2017, The Journal of Neuroscience.

[12]  N. Seidah,et al.  New insights of altered lipid profile in Fragile X Syndrome , 2017, PloS one.

[13]  Shui-bing Liu,et al.  Imbalance between TNFα and progranulin contributes to memory impairment and anxiety in sleep-deprived mice , 2017, Scientific Reports.

[14]  C. Mandyam,et al.  Neuron-Targeted Caveolin-1 Improves Molecular Signaling, Plasticity, and Behavior Dependent on the Hippocampus in Adult and Aged Mice , 2017, Biological Psychiatry.

[15]  Si Jin,et al.  A novel mechanism of action for salidroside to alleviate diabetic albuminuria: effects on albumin transcytosis across glomerular endothelial cells. , 2016, American journal of physiology. Endocrinology and metabolism.

[16]  B. Bardoni,et al.  Fragile X mental retardation protein (FMRP) interacting proteins exhibit different expression patterns during development , 2015, International Journal of Developmental Neuroscience.

[17]  M. Zhuo,et al.  Increased coupling of caveolin‐1 and estrogen receptor α contributes to the fragile X syndrome , 2015, Annals of neurology.

[18]  Li-na Sun,et al.  Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation. , 2014, International immunopharmacology.

[19]  J. Rawlins,et al.  Hippocampal synaptic plasticity, spatial memory and anxiety , 2014, Nature Reviews Neuroscience.

[20]  P. L. Becker,et al.  Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells. ROLE OF CHOLESTEROL-RICH MICRODOMAINS AND FOCAL ADHESIONS IN ANGIOTENSIN II SIGNALING. , 2013, The Journal of Biological Chemistry.

[21]  A. Tufro.  Cholesterol Accumulation in Podocytes: A Potential Novel Targetable Pathway in Diabetic Nephropathy , 2013, Diabetes.

[22]  J. Darnell,et al.  The translation of translational control by FMRP: therapeutic targets for FXS , 2013, Nature Neuroscience.

[23]  M. Bear,et al.  Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome , 2013, Neuron.

[24]  M. Beal,et al.  Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease , 2012, The Journal of experimental medicine.

[25]  P. Insel,et al.  Neuron-targeted Caveolin-1 Protein Enhances Signaling and Promotes Arborization of Primary Neurons* , 2011, The Journal of Biological Chemistry.

[26]  Atul Arya,et al.  Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats , 2011, Molecular and Cellular Biochemistry.

[27]  M. Bennett,et al.  Caveolin-1 knockout mice exhibit impaired induction of mGluR-dependent long-term depression at CA3-CA1 synapses , 2010, Proceedings of the National Academy of Sciences.

[28]  R. Zukin,et al.  Regulation of Group I Metabotropic Glutamate Receptor Trafficking and Signaling by the Caveolar/Lipid Raft Pathway , 2009, The Journal of Neuroscience.

[29]  M. Zhuo,et al.  FMRP Acts as a Key Messenger for Dopamine Modulation in the Forebrain , 2008, Neuron.

[30]  J. Buschiazzo,et al.  Inhibition of Bufo arenarum oocyte maturation induced by cholesterol depletion by methyl-beta-cyclodextrin. Role of low-density caveolae-like membranes. , 2008, Biochimica et biophysica acta.

[31]  Alcino J. Silva,et al.  Interactions between the NR2B Receptor and CaMKII Modulate Synaptic Plasticity and Spatial Learning , 2007, The Journal of Neuroscience.

[32]  J. Krepinsky,et al.  Caveolin-1 phosphorylation is required for stretch-induced EGFR and Akt activation in mesangial cells. , 2007, Cellular signalling.

[33]  Chris J. McBain,et al.  The Role of the GluR2 Subunit in AMPA Receptor Function and Synaptic Plasticity , 2007, Neuron.

[34]  R. Parton,et al.  The multiple faces of caveolae , 2007, Nature Reviews Molecular Cell Biology.

[35]  Sara C. Verosky,et al.  Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome. , 2006, Behavioral neuroscience.

[36]  E. Cattaneo,et al.  Cholesterol dysfunction in neurodegenerative diseases: Is Huntington's disease in the list? , 2006, Progress in Neurobiology.

[37]  Richard Paylor,et al.  Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression , 2006, Neuron.

[38]  I. Weiler,et al.  Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond , 2006, The Journal of Neuroscience.

[39]  C. Bagni,et al.  mRNPs, polysomes or granules: FMRP in neuronal protein synthesis , 2006, Current Opinion in Neurobiology.

[40]  S. Warren,et al.  Transcription, translation and fragile X syndrome. , 2006, Current opinion in genetics & development.

[41]  K. M. Huber,et al.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. , 2006, Journal of neurophysiology.

[42]  M. Tranfaglia,et al.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.

[43]  W. Greenough,et al.  From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome , 2005, Nature Reviews Neuroscience.

[44]  K. M. Huber,et al.  Developmental Switch in Synaptic Mechanisms of Hippocampal Metabotropic Glutamate Receptor-Dependent Long-Term Depression , 2005, The Journal of Neuroscience.

[45]  M. Lisanti,et al.  Role of caveolae and caveolins in health and disease. , 2004, Physiological reviews.

[46]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[47]  L. Pelkmans,et al.  Caveolin-Stabilized Membrane Domains as Multifunctional Transport and Sorting Devices in Endocytic Membrane Traffic , 2004, Cell.

[48]  Eric Klann,et al.  Activation of the Phosphoinositide 3-Kinase-Akt-Mammalian Target of Rapamycin Signaling Pathway Is Required for Metabotropic Glutamate Receptor-Dependent Long-Term Depression , 2004, The Journal of Neuroscience.

[49]  Mark F Bear,et al.  The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.

[50]  J. Poirier,et al.  The Caveolin Scaffolding Domain Modifies 2-Amino-3-hydroxy-5-methyl-4-isoxazole Propionate Receptor Binding Properties by Inhibiting Phospholipase A2 Activity* , 2004, Journal of Biological Chemistry.

[51]  R. Petralia,et al.  Internalization at glutamatergic synapses during development , 2003, The European journal of neuroscience.

[52]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Malenka,et al.  AMPA receptor trafficking and synaptic plasticity. , 2002, Annual review of neuroscience.

[54]  M. Bear,et al.  Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. , 2001, Journal of neurophysiology.

[55]  H. Nawa,et al.  Biochemical evidence for localization of AMPA-type glutamate receptor subunits in the dendritic raft. , 2001, Brain research. Molecular brain research.

[56]  A. Bist,et al.  Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Richard G. W. Anderson,et al.  A Role for Caveolin in Transport of Cholesterol from Endoplasmic Reticulum to Plasma Membrane* , 1996, The Journal of Biological Chemistry.

[58]  M. Lisanti,et al.  Expression and Characterization of Recombinant Caveolin , 1996, The Journal of Biological Chemistry.

[59]  F. Wieland,et al.  VIP21/caveolin is a cholesterol-binding protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Lisanti,et al.  Oligomeric structure of caveolin: implications for caveolae membrane organization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Lisanti,et al.  Expression and Characterization of Recombinant Caveolin PURIFICATION BY POLYHISTIDINE TAGGING AND CHOLESTEROL-DEPENDENT INCORPORATION INTO DEFINED LIPID MEMBRANES* , 1995 .

[62]  J. Sutcliffe,et al.  DNA methylation represses FMR-1 transcription in fragile X syndrome. , 1992, Human molecular genetics.